化学名称: Methyl ((S)-1-((2S,5S)-2-(9-(2-((2S,4S)-4-(methoxymethyl)-1-nitrosopyrrolidin-2-yl)-1H-imidazol-5-yl)-1,11-dihydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-2-yl)-5-methylpyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate
微笑: O=C(OC)N[C@@H](C(C)C)C(N1[C@H](C2=NC3=CC=C4C=C5C(OCC6=C5C=CC(C7=CN=C([C@H]8N(N=O)C[C@@H](COC)C8)N7)=C6)=CC4=C3N2)CC[C@@H]1C)=O
UPLC Separation of forced degradation and process related impurities of Velpatasvir and structure elucidation by online LC-Quadrupole-Time of flight-Tandem mass Spectrometry
Md. Sattar Abdul*, Suneetha A.Research Journal of Pharmacy and Technology
Year : 2019, Volume : 12, Issue : 2
First page : ( 477) Last page : ( 482)
Stability indicating RP-HPLC Method development and Validation for the Estimation of Sofosbuvir, Velpatasvir and Voxilaprevir in Bulk and Pharmaceutical dosage form
Kokkirala, Tej Kumar; Suryakala, Duvvuri. Research Journal of Pharmacy and Technology; RaipurVol. 13, Iss. 11, (Nov 2020): 5063-5071. DOI:10.5958/0974-360X.2020.00887.2
RP-HPLC Method Development and Validation for Velpatasvir and Voxilaprevir by Simultaneous Determination in Bulk and Their Pharmaceutical Dosage Forms
DebasishSwainaAmrej SinghYadavaChandrasekharSasapuaVenkatakrishnaAkulabGananadhamuSamanthulaa
Microchemical JournalVolume 155, June 2020, 104657